«Asceneuron»
Asceneuron
Companies
Asceneuron develops effective therapeutics for orphan tauopathies and Alzheimer’s disease.
Investors
Johnson & Johnson Innovation
Johnson & Johnson Innovation
M Ventures
Michael J. Fox Foundation
Sofinnova Partners
SR One
Industry:
Global Health Challenges
Headquarters:
Switzerland
Visit Website
info@asceneuron.com
Register and Claim Ownership